Can a smaller incision for kidney stone surgery reduce recovery without sacrificing results?

NCT ID NCT07697677

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial compares two surgical techniques for removing large or complex kidney stones: a modified mini version using a smaller access sheath (20 Fr) versus the standard approach (24 Fr). The goal is to see if the mini procedure causes less bleeding and pain while still clearing stones just as effectively. About 1,380 adults with complex kidney stones will be randomly assigned to one of the two procedures across eight hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Modified mini percutaneous nephrolithotomy (mini-PCNL) using a 20 Fr access sheath
What this could lead to
If successful, this could offer a less invasive surgical option for complex kidney stones, reducing bleeding, pain, and recovery time while still effectively clearing stones.
What could go wrong
This is a comparative effectiveness trial, not a new drug or device. The mini approach may not clear stones as well as the standard method, or benefits may be modest. Results depend on surgeon skill and patient anatomy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLEX RENAL CALCULI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Kidney Calculi nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Guangzhou Medical University

    RECRUITING

    Guangzhou, Guangdong, 510120, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.